Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Loperamide Abuse Associated with Cardiac Dysrhythmia and Death

By Frank LoVecchio, DO, MPH, FACEP, ABMT | on July 15, 2016 | 0 Comment
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Oral loperamide abuse postings to web-based forums increased tenfold between 2010 and 2011. A majority of user-generated content pertaining to loperamide reported using the medication to self-treat opioid withdrawal (70 percent).3 Users also cited abusing the medication for its euphoric properties (25 percent). The Upstate New York Poison Center experienced a sevenfold increase in calls related to loperamide abuse or misuse from 2011 through 2015. That is consistent with national poison data, which reported a 71 percent increase in calls related to intentional loperamide exposure from 2011 through 2014.

You Might Also Like
  • FDA Asks Drugmakers to Limit Amount of Opioid Drug in Packaging
  • FDA Panel Backs Teva’s Abuse-Resistant Opioid Painkiller
  • Emergency Physicians Urged Not to Prescribe New Opioid, Zohydro ER, Given High Potential for Abuse

If the dose does make the poison, then it won’t come as a surprise to most clinicians that 100 times the therapeutic dose of almost anything, including loperamide, would cause toxicity.


Dr. LoVecchio is vice-chairman and research director for Maricopa Medical Center and co-medical director for Banner Poison and Drug Information Center, both in Phoenix, and professor of emergency medicine at The University of Arizona in Tucson.

References

  1. Eggleston W, Clark KH, Marraffa JM. Loperamide abuse associated with cardiac dysrhythmia and death (published online ahead of print April 26, 2016). Ann Emerg Med. doi:10.1016/j.annemergmed.2016.03.047.
  2. FAERS Reporting by Healthcare Providers and Consumers by Year. U.S. Food and Drug Administration website. Accessed July 11, 2016.
  3. Dierksen J, Gonsoulin M, Walterscheid JP. Poor man’s methadone: a case report of loperamide toxicity. Am J Forensic Med Pathol. 2015;36(4):268-270.

Pages: 1 2 | Single Page

Current Issue

ACEP Now: November 2025

Download PDF

Read More

No Responses to “Loperamide Abuse Associated with Cardiac Dysrhythmia and Death”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603